For citations:
Arutyunov G.P., Boytsov S.A., Voyevoda M.I., Gurevich V.S., Drapkina O.M., Kukharchuk V.V., Martynov A.I., Sergiyenko I.V., Shestakova M.V., Aliyeva A.S., Akhmedzhanov N.M., Bubnova M.G., Galyavich А.S., Gordeyev I.G., Ezhov M.V., Karpov Yu.A., Konstantinov V.O., Nedogoda S.V., Nifontov E.M., Orlova Ya.A., Panov A.V., Sayganov S.A., Skibitskiy V.V., Tarlovskaya E.I., Urazgildeyeva S.A., Khalimov Yu.Sh. Correction of Hypertriglyceridemia as the Way to Reduce Residual Risk in Diseases Caused by Atherosclerosis. Conclusion of the Advisory Board of the Russian Society of Cardiology, the Russian Scientific Medical Society of Therapists, the Eurasian Association of Therapists, the Russian National Atherosclerosis Society, the Russian Association of Endocrinologists, and the National League of Cardiologic Genetics. Rational Pharmacotherapy in Cardiology. 2019;15(2):282-288. (In Russ.) https://doi.org/10.20996/1819-6446-2019-15-2-282-288
Email this article 